Moreover, in the bio portal TGCA AML cohort, overexpression of both GPX1 and GPX4 which is found in a significant subset of patients is associated with a poor prognosis [36]
In its annual report for 2024, Bayer said it registered encouraging sales growth for Eylea in a number of areas, including Europe and Canada, thanks to higher volumes and prices. This growth was bolstered by Eylea HD for conditions like wet age-related macular degeneration (AMD), diabetic macular edema and diabetic retinopathy, allowing for more flexible dosing schedules
It was particularly interesting to learn what lasting impacts a GLP-1 medication may have on consumers they continue to try to maintain those healthy eating habits even as the food noise returns. As a result of the study, we have identified key implications for brands and retailers regarding product prioritizations and how we can best convey product benefits to support weight loss journeys, both during and post GLP-1 therapy, said Jami McDermid, CROSSMARK Sales Agency President
Stat Med (2009) 28(25):3083107